AKT1 and acute myeloid leukemia: The above results suggested that the combination of CDM and ASA inhibited cell proliferation, induced cell cycle arrest and promoted apoptosis in AML-MDS cells partially through suppressing the PI3K/AKT pathway (Figure 8).